Esperion Therapeutics
ESPR
ESPR
109 hedge funds and large institutions have $267M invested in Esperion Therapeutics in 2016 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 40 increasing their positions, 28 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
27% less capital invested
Capital invested by funds: $366M → $267M (-$99M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
109
Holding in Top 10
2
Calls
$3.74M
Puts
$2.31M
Top Buyers
| 1 | +$10.3M | |
| 2 | +$3.13M | |
| 3 | +$3.12M | |
| 4 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
+$2.34M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$2.12M |
Top Sellers
| 1 | -$14M | |
| 2 | -$11.9M | |
| 3 | -$4.98M | |
| 4 |
Renaissance Technologies
New York
|
-$4.29M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$2.96M |